The London & Southeast Market
London and the Southeast is the UK's primary market for Pharmaceuticals & Life Sciences — and the most demanding regulatory environment in the country. FCA oversight, ICO enforcement, and the post-Brexit regulatory framework create a compliance surface area that is evolving faster than most technology vendor certification cycles can track.
Pharmaceuticals & Life Sciences organizations in London operate with regulatory scrutiny that is active and consequential. FCA, PRA, ICO, and CMA enforcement actions have reshaped compliance expectations across every major UK sector. We deploy with the current UK regulatory framework mapped to the architecture — not the version that was current when the vendor's compliance team last updated their documentation.
Compliance Coverage
Every system we deploy for Pharmaceuticals & Life Sciences in London & Southeast is FDA 21 CFR Part 11-compliant from architecture through deployment. FDA 21 CFR Part 11 and HIPAA compliance is enforced automatically at every commit — not assessed after the fact.
Engagement Scope
Duration: 8–16 weeks
A focused team deployed against a single Pharmaceuticals & Life Sciences platform in London & Southeast. FDA 21 CFR Part 11 and HIPAA-compliant architecture from day one. Fixed price, fixed output, no discovery phase.
Duration: 3–9 months
40–100 engineers running parallel workstreams across a Pharmaceuticals & Life Sciences transformation in London & Southeast. Multi-system compliance governance and FDA 21 CFR Part 11 and HIPAA certification maintained across the full program.
Duration: 6–18 months
100–250+ engineers owning the complete technology infrastructure for a Pharmaceuticals & Life Sciences organization in London & Southeast. Full FDA 21 CFR Part 11 and HIPAA compliance across every system, every integration, every deployment.